Angela C. Davies, Ph.D. - Publications

2001 University of California, Berkeley, Berkeley, CA 
Race, Ethnicity, Anthropology, Minorities

60 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2019 Davies AC, Harris D, Banks-Gatenby A, Brass A. Problem-based learning in clinical bioinformatics education: Does it help to create communities of practice? Plos Computational Biology. 15: e1006746. PMID 31246944 DOI: 10.1371/journal.pcbi.1006746  0.01
2018 Ciznadija D, Astaturov I, Cheng H, Peled N, Jaskowiak J, Davies A, Sidransky D. Abstract A018: Patient-derived xenograft (PDX) models of NSCLC reflect clinical drug responses and predict effective treatments for patients Molecular Cancer Therapeutics. 17. DOI: 10.1158/1535-7163.Targ-17-A018  1
2018 Verma B, Mancini M, Davies A, Sidransky D, Goodwin N. Abstract A016: NOG-EXL mice have superior immune cell engraftment and lineage development in the human immune system (HIS) model, the ImmunoGraft Molecular Cancer Therapeutics. 17. DOI: 10.1158/1535-7163.Targ-17-A016  1
2017 Izumchenko E, Paz K, Ciznadija D, Sloma I, Katz A, Vasquez-Dunddel D, Ben-Zvi I, Stebbing J, McGuire W, Harris W, Maki R, Gaya A, Bedi A, Zacharoulis S, Ravi R, ... ... Davies A, et al. Patient-derived xenografts effectively capture responses to oncology therapy in a heterogeneous cohort of patients with solid tumors. Annals of Oncology : Official Journal of the European Society For Medical Oncology. PMID 28945830 DOI: 10.1093/Annonc/Mdx416  1
2017 Ciznadija D, Sonnenblick A, Jaskowiak J, Davies A, Sidransky D. Abstract 1836: Patient-derived xenograft (PDX) models expressing HER2 reflect clinical responses to targeted HER2 inhibition Cancer Research. 77: 1836-1836. DOI: 10.1158/1538-7445.Am2017-1836  1
2017 Cerna D, Ciznadija D, Verma B, Sidransky D, Izumchenko E, Davies A, Mancini M. Abstract 1648: ImmunoGraft® platform for the evaluation of Immuno-Oncology agents in PDX tumors models Cancer Research. 77: 1648-1648. DOI: 10.1158/1538-7445.Am2017-1648  1
2016 Cohen SJ, O'Neil BH, Berlin J, Ames P, McKinley M, Horan J, Catalano PM, Davies A, Weekes CD, Leichman L. A phase 1b study of erlotinib in combination with gemcitabine and nab-paclitaxel in patients with previously untreated advanced pancreatic cancer: an Academic Oncology GI Cancer Consortium study. Cancer Chemotherapy and Pharmacology. PMID 26886016 DOI: 10.1007/S00280-016-2981-2  1
2016 Katz A, Pollock RE, Wexler LH, Rodriguez-Galindo C, Trent JC, Maki R, Jaskowiak J, Ryland L, Ciznadija D, Davies A, Paz K. Abstract B40: Mouse clinical trials: integrating PDX models of sarcoma subtypes with genomics to replicate patient responses to cancer therapeutics Clinical Cancer Research. 22. DOI: 10.1158/1557-3265.Pdx16-B40  1
2016 Davies A, Hidalgo M, Stebbing J, Ciznadija D, Katz A, Sidransky D. Mouse clinical trials of pancreatic cancer: Integration of PDX models with genomics to improve patient outcomes to chemotherapeutics Annals of Oncology. 27. DOI: 10.1093/Annonc/Mdw392.04  1
2016 Davies A, Stebbing J, Zacharoulis S, Gaya A, McGuire W, Harris W, Maki R, Hidalgo M, Vasquez-Dunddel D, Ciznadija D, Katz A, Sidransky D. Patient-derived xenografts effectively capture patient clinical responses to oncology therapy European Journal of Cancer. 61. DOI: 10.1016/S0959-8049(16)61717-3  1
2016 Davies A, Hou J, Shih LM, Wright JD, Ciznadija D, Katz A, Sidransky D. Patient-derived xenograft (PDX) models of BRCA-deficient and BRCA-like ovarian tumors reflect clinical responses to PARP inhibition European Journal of Cancer. 69. DOI: 10.1016/S0959-8049(16)32928-8  1
2016 Cerna D, Ciznadija D, zvi IB, Sloma I, Sidransky D, Davies A, Goodwin N. Genomic characterization of immune targets in patient-derived xenograft models for translational assessment of immunotherapy European Journal of Cancer. 69. DOI: 10.1016/S0959-8049(16)32927-6  1
2015 Davies AC, Nicol CJ, Radford AN. Effect of reward downshift on the behaviour and physiology of chickens. Animal Behaviour. 105: 21-28. PMID 26257402 DOI: 10.1016/j.anbehav.2015.04.005  1
2015 Davies AC, Radford AN, Pettersson IC, Yang FP, Nicol CJ. Elevated arousal at time of decision-making is not the arbiter of risk avoidance in chickens. Scientific Reports. 5: 8200. PMID 25643655 DOI: 10.1038/srep08200  1
2015 Davies AC. Stereo sound recording and reproduction? Remembering the history [sp History] Ieee Signal Processing Magazine. 32: 14-16. DOI: 10.1109/MSP.2015.2440191  1
2014 Stebbing J, Zacharoulis S, Gaya A, McGuire W, Harris W, Maki RG, Hidalgo M, Davies A, Vasquez-Dunddel D, Ciznadija D, Katz A, Sidransky D, Paz K. 1573PDPATIENT-DERIVED XENOGRAFTS ACCURATELY CAPTURE CLINICAL RESPONSES TO TREATMENT. Annals of Oncology : Official Journal of the European Society For Medical Oncology. 25: iv547. PMID 28171498 DOI: 10.1093/Annonc/Mdu358.4  1
2014 Davies AC, Nicol CJ, Persson ME, Radford AN. Behavioural and physiological effects of finely balanced decision-making in chickens. Plos One. 9: e108809. PMID 25275440 DOI: 10.1371/journal.pone.0108809  1
2014 Davies AC, Radford AN, Nicol CJ. Behavioural and physiological expression of arousal during decision-making in laying hens. Physiology & Behavior. 123: 93-9. PMID 24432355  1
2013 Davies AC, Radford AN, Nicol CJ. Behavioural and physiological expression of arousal during decision-making in laying hens. Physiology & Behavior. PMID 24513559 DOI: 10.1016/j.physbeh.2013.10.008  1
2013 Davies AC. IEEE region 8 in a persian market Ieee Technology and Society Magazine. 32: 66-73. DOI: 10.1109/MTS.2013.2259321  0.01
2012 Blagrove M, Fouquet NC, Baird AL, Pace-Schott EF, Davies AC, Neuschaffer JL, Henley-Einion JA, Weidemann CT, Thome J, McNamara P, Turnbull OH. Association of salivary-assessed oxytocin and cortisol levels with time of night and sleep stage. Journal of Neural Transmission (Vienna, Austria : 1996). 119: 1223-32. PMID 22911329 DOI: 10.1007/S00702-012-0880-1  1
2012 Gitlitz BJ, Tsao-Wei DD, Groshen S, Davies A, Koczywas M, Belani CP, Argiris A, Ramalingam S, Vokes EE, Edelman M, Hoffman P, Ballas MS, Liu SV, Gandara DR. A phase II study of halichondrin B analog eribulin mesylate (E7389) in patients with advanced non-small cell lung cancer previously treated with a taxane: a California cancer consortium trial. Journal of Thoracic Oncology : Official Publication of the International Association For the Study of Lung Cancer. 7: 574-8. PMID 22198425 DOI: 10.1097/Jto.0B013E31823F43Ca  1
2012 Chao J, Synold TW, Morgan RJ, Kunos C, Longmate J, Lenz HJ, Lim D, Shibata S, Chung V, Stoller RG, Belani CP, Gandara DR, McNamara M, Gitlitz BJ, Lau DH, ... ... Davies A, et al. A phase I and pharmacokinetic study of oral 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP, NSC #663249) in the treatment of advanced-stage solid cancers: a California Cancer Consortium Study. Cancer Chemotherapy and Pharmacology. 69: 835-43. PMID 22105720 DOI: 10.1007/S00280-011-1779-5  1
2012 Davies AC. Go East, Region 8, go East 3rd Region-8 Ieee History of Electro - Technology Conference: the Origins of Electrotechnologies, Histelcon 2012 - Conference Proceedings. DOI: 10.1109/HISTELCON.2012.6487565  0.01
2012 Davies AC. The rise and Fall of the military wavemeter: British military wavemeters of the 20th century 3rd Region-8 Ieee History of Electro - Technology Conference: the Origins of Electrotechnologies, Histelcon 2012 - Conference Proceedings. DOI: 10.1109/HISTELCON.2012.6487564  0.01
2011 Blagrove M, Fouquet NC, Henley-Einion JA, Pace-Schott EF, Davies AC, Neuschaffer JL, Turnbull OH. Assessing the dream-lag effect for REM and NREM stage 2 dreams. Plos One. 6: e26708. PMID 22046336 DOI: 10.1371/journal.pone.0026708  1
2011 Leal TB, Remick SC, Takimoto CH, Ramanathan RK, Davies A, Egorin MJ, Hamilton A, LoRusso PA, Shibata S, Lenz HJ, Mier J, Sarantopoulos J, Mani S, Wright JJ, Ivy SP, et al. Dose-escalating and pharmacological study of bortezomib in adult cancer patients with impaired renal function: a National Cancer Institute Organ Dysfunction Working Group Study. Cancer Chemotherapy and Pharmacology. 68: 1439-47. PMID 21479634 DOI: 10.1007/S00280-011-1637-5  1
2009 Caldwell ND, Roehrich JK, Davies AC. Procuring complex performance in construction: London Heathrow Terminal 5 and a Private Finance Initiative hospital Journal of Purchasing and Supply Management. 15: 178-186. DOI: 10.1016/j.pursup.2009.05.006  0.01
2009 Davies AC. British Army battlefield radios of the 1940s 2009 Applied Electronics International Conference, Ae 2009. 11-16.  0.01
2008 Rivera E, Lee J, Davies A. Clinical development of ixabepilone and other epothilones in patients with advanced solid tumors. The Oncologist. 13: 1207-23. PMID 19088324 DOI: 10.1634/Theoncologist.2008-0143  0.01
2008 Lau D, Johl J, Huynh M, Davies A, Tanaka M, Lara P, Gandara D. Population-based phase I trial of irinotecan and epirubicin. American Journal of Clinical Oncology. 31: 226-30. PMID 18525299 DOI: 10.1097/Coc.0B013E3181605440  1
2008 Leon N, Davies AC. Managed service paradox Ibm Systems Journal. 47: 153-166. DOI: 10.1147/sj.471.0153  0.01
2008 Davies AC. WW2 British Army battlefield wireless communications equipment Ieee History of Telecommunications Conference, Histelcon 2008. 83-90. DOI: 10.1109/HISTELCON.2008.4668720  0.01
2007 Ho C, Davies A, Mack P, Gandara DR. Dual Inhibition: Combining Epidermal Growth Factor–Targeted Therapies in Non–Small-Cell Lung Cancer Clinical Lung Cancer. 8: 420-424. PMID 17681094 DOI: 10.3816/Clc.2007.N.025  1
2007 Davies AC, Velastin SA. A progress review of intelligent CCTV surveillance systems Proceedings of the Third Workshop - 2005 Ieee Intelligent Data Acquisition and Advanced Computing Systems: Technology and Applications, Idaacs 2005. 417-423. DOI: 10.1109/IDAACS.2005.283015  0.01
2006 Ho C, Ross H, Davies A. Phase II Trial of Pemetrexed in Patients with Selected Stage IIIB/IV Bronchioloalveolar Carcinoma Clinical Lung Cancer. 8: 220-222. PMID 17239300 DOI: 10.3816/Clc.2006.N.052  1
2006 Davies AC, Birley H, Chiganze A. Chlamydia is being managed in primary care. Bmj (Clinical Research Ed.). 332: 551. PMID 16513727 DOI: 10.1136/bmj.332.7540.551  0.01
2006 Mulkerin D, Remick S, Ramanathan R, Hamilton A, Takimoto C, Davies A, Ivy P, Karol M, Kolesar J, Wright J. A dose-escalating and pharmacologic study of bortezomib in adult cancer patients with impaired renal function Journal of Clinical Oncology. 24: 2032-2032. DOI: 10.1200/Jco.2006.24.18_Suppl.2032  1
2006 Kris MG, Giaccone G, Davies A, Fukuoka M, Garfield DH, Jassem J, Quoix EA, Sandler AB, Scagliotti GV, Meerbeeck JPV, West H. Systemic Therapy of Bronchioloalveolar Carcinoma: Results of the First IASLC/ASCO Consensus Conference on Bronchioloalveolar Carcinoma Journal of Thoracic Oncology. 1: 32. DOI: 10.1016/S1556-0864(15)30007-1  1
2005 Huynh MT, Fehrenbacher L, West H, Davies A, Simmons J, Lara P, Yarorkovsky L, Russin M, Gandara D, Lau D. A multi-institution phase II trial of irinotecan and carboplatin for extensive or relapsed small-cell lung cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 7169. PMID 27944988 DOI: 10.1200/Jco.2005.23.16_Suppl.7169  1
2005 Gandara D, Narayan S, Lara PN, Goldberg Z, Davies A, Lau DHM, Mack P, Gumerlock P, Vijayakumar S. Integration of novel therapeutics into combined modality therapy of locally advanced non-small cell lung cancer. Clinical Cancer Research. 11. PMID 16000614 DOI: 10.1158/1078-0432.Ccr-05-9012  1
2005 Herbst R, Davies A, Johnson B, Natale R, Dang T, Murren J, Schiller J, Garland L, Miller V, Mendelson D, Melenevsky Y, Devries D, Abbeele AVD, Eberhard D, Lyons B, et al. O-187 Efficacy and safety of single agent pertuzumab (rhuMAb 2C4), a HER dimerization inhibitor, in Non-Small Cell Lung Cancer (NSCLC) patients after prior chemotherapy Lung Cancer. 49. DOI: 10.1016/S0169-5002(05)80321-6  0.01
2005 Davies A, Lara P, Lau D, Mack P, Gumerlock P, Gandara D. O-185 Overcoming hypothesized antagonism with intermittent dosingof erlotinib in combination with docetaxel (DOC) in non-small cell lung cancer (NSCLC): A phase I study Lung Cancer. 49. DOI: 10.1016/S0169-5002(05)80319-8  1
2004 Martel CL, Li Y, Beckett L, Chew H, Christensen S, Davies A, Lam KS, Lau DH, Meyers FJ, O'donnell RT, Richman C, Scudder S, Tanaka M, Tuscano J, Welborn J, et al. An evaluation of barriers to accrual in the era of legislation requiring insurance coverage of cancer clinical trial costs in California. Cancer Journal (Sudbury, Mass.). 10: 294-300. PMID 15530258 DOI: 10.1097/00130404-200409000-00006  1
2003 Davies A, Lara PN, Mack PC, Gumerlock PH, Turrell C, Doroshow JH, Schenkein D, Gandara DR. P-245 The proteasome inhibitor, bortezomib, in combination with gemcitabine (gem) and carboplatin (carbon) in advanced non-small cell lung cancer (NSCLC): A phase I study Lung Cancer. 41. DOI: 10.1016/S0169-5002(03)92214-8  1
2002 Lara PN, Goldberg Z, Davies A, Lau DHM, Gandara DR. Concurrent chemoradiation strategies in the management of unresectable stage III non-small-cell lung cancer. Clinical Lung Cancer. 3. PMID 14720347 DOI: 10.3816/Clc.2002.S.013  1
2002 Davies A, Gandara DR, Lara PN, Goldberg Z, Roberts P, Lau DH. Current and future therapeutic approaches in locally advanced (stage III) non-small cell lung cancer. Seminars in Oncology. 29: 10-16. DOI: 10.1016/S0093-7754(02)90002-3  1
1999 Leach SA, Williams A, Davies AC, Wilson J, Marsh PD, Humphrey TJ. Aerosol route enhances the contamination of intact eggs and muscle of experimentally infected laying hens by Salmonella typhimurium DT104. Fems Microbiology Letters. 171: 203-7. PMID 10077845  1
1998 Davies AC, Olomolaiye OO, Bidwell JL. Sp1 screening test in risk assessment for osteoporosis. The Journal of Rheumatology. 25: 2480-1. PMID 9858458  0.01
1998 Williams A, Davies AC, Wilson J, Marsh PD, Leach S, Humphrey TJ. Contamination of the contents of intact eggs by Salmonella typhimurium DT104. The Veterinary Record. 143: 562-3. PMID 9854321  1
1986 Froggatt P, Davies AC. David Smyth Torrens: physiologist and horologist. Hermathena. 11-31. PMID 11617048  0.01
1986 Rudland PS, Paterson FC, Monaghan P, Davies AC, Warburton MJ. Isolation and properties of rat cell lines morphologically intermediate between cultured mammary epithelial and myoepithelial-like cells. Developmental Biology. 113: 388-405. PMID 2419187 DOI: 10.1016/0012-1606(86)90174-0  1
1985 Davies AC, Keightley A, Borthwick-Clarke A, Walters HL. The use of a low-osmolality contrast medium in hysterosalpingography: comparison with a conventional contrast medium. Clinical Radiology. 36: 533-6. PMID 3907933  0.01
1983 Young AR, Magnus IA, Davies AC, Smith NP. A comparison of the phototumorigenic potential of 8-MOP and 5-MOP in hairless albino mice exposed to solar simulated radiation. The British Journal of Dermatology. 108: 507-18. PMID 6849820  1
1983 Rudland PS, Paterson FC, Davies AC, Warburton MJ. Retinoid-specific induction of differentiation and reduction of the DNA synthesis rate and tumor-forming ability of a stem cell line from a rat mammary tumor. Journal of the National Cancer Institute. 70: 949-58. PMID 6573540  1
1983 Rudland PS, Hughes CM, Davies AC, Warburton MJ. Immunocytochemical demonstration of hormonally regulable casein in tumors produced by a rat mammary stem cell line. Cancer Research. 43: 3305-9. PMID 6189596  1
1980 Timmis AD, Smallpeice C, Davies AC, Macarthur AM, Gishen P, Jackson G. Intracardiac spread of intravenous leiomyomatosis with successful surgical excision. The New England Journal of Medicine. 303: 1043-4. PMID 7421892 DOI: 10.1056/NEJM198010303031806  0.01
1980 Davies AC. Total patient care in theatre--an idea. Natnews. 17: 10-3. PMID 6898837  0.01
1977 Davies AC, Chalmers I, Fahmy DR. Predicting fetal death. British Medical Journal. 1: 443. PMID 837148  0.01
1969 Davies AC, Lloyd DS, Binnie CD. A pseudo-random binary sequence generator: an aid to testing low frequency-wave analysers. Electroencephalography and Clinical Neurophysiology. 27: 334-5. PMID 4185699  0.01
Show low-probability matches.